ResMed D&A increased by 0.5% to $7.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.5%, from $7.44M to $7.85M. Over 4 years (FY 2021 to FY 2025), D&A shows a downward trend with a -32.7% CAGR.
Analysis
How to read this metric
Higher levels often indicate significant recent capital investment or large historical acquisitions, while lower levels may suggest aging assets.
Detailed definition
Depreciation and amortization represent the systematic allocation of the cost of tangible and intangible assets over the...
Peer comparison
High in capital-intensive industries like healthcare and manufacturing; peers often report this as a significant non-cash drag on earnings.
depreciation_and_amortizationHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.72M | $39.10M | $40.79M | $10.98M | $37.41M | $6.37M | $7.31M | $8.32M | $8.40M | $8.91M | $8.26M | $7.81M | $7.99M | $7.67M | $7.63M | $7.44M | $9.37M | $7.82M | $7.81M | $7.85M |
| QoQ Change | — | +6.5% | +4.3% | -73.1% | +240.7% | -83.0% | +14.6% | +13.9% | +0.9% | +6.1% | -7.3% | -5.4% | +2.2% | -4.0% | -0.5% | -2.5% | +25.8% | -16.5% | -0.2% | +0.5% |
| YoY Change | — | — | — | — | +1.9% | -83.7% | -82.1% | -24.2% | -77.6% | +39.8% | +13.0% | -6.1% | -4.9% | -13.9% | -7.5% | -4.7% | +17.3% | +2.0% | +2.3% | +5.5% |
Product Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Residential Care Software | — | $6.46M | $6.40M | $6.26M | $6.34M | $6.40M | $6.39M | $6.43M |
| Sleep And Breathing Health | — | $1.21M | $1.23M | $1.18M | $3.02M | $1.42M | $1.42M | $1.42M |
| Sleep and Respiratory Care | $1.22M | — | — | — | — | — | — | — |
| Software as a Service | $6.86M | — | — | — | — | — | — | — |
| Total | $7.99M | $7.67M | $7.63M | $7.44M | $9.37M | $7.82M | $7.81M | $7.85M |
Software as a Service is derived from annual filings.
Sleep and Respiratory Care, Software as a Service were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments — Total Sleep and Respiratory Care
| Segment | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| Sleep and Respiratory Care | $19.77M | $18.53M | $21.20M | $23.04M | $20.52M | $21.96M | $21.83M | $21.76M |
| Total | $6.37M | $7.31M | $8.32M | $8.40M | $8.91M | $8.26M | $7.81M | $7.99M |
Software as a Service is derived from annual filings.
Sleep and Respiratory Care, Software as a Service, Total Sleep and Respiratory Care were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments — Sleep And Breathing Health
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|
| Sleep And Breathing Health | $23.02M | $25.25M | $22.82M | $39.46M | $25.03M | $27.31M | $36.86M |
| Residential Care Software | $2.37M | $2.24M | $2.25M | $2.61M | $2.62M | $2.73M | $2.75M |
| Total | $7.67M | $7.63M | $7.44M | $9.37M | $7.82M | $7.81M | $7.85M |
D&A at Other Companies
Frequently Asked Questions
- What is ResMed's d&a?
- ResMed (RMD) reported d&a of $7.85M in Q1 2026.
- How has ResMed's d&a changed year-over-year?
- ResMed's d&a increased by 5.5% year-over-year, from $7.44M to $7.85M.
- What is the long-term trend for ResMed's d&a?
- Over 4 years (2021 to 2025), ResMed's d&a has grown at a -32.7% compound annual growth rate (CAGR), from $156.76M to $32.12M.
- What does d&a mean?
- The non-cash expense that spreads the cost of physical and intangible assets over their useful life.